Spots Global Cancer Trial Database for ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases
Official Title: A Phase II, Open-Label, Multi-Center Study of ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases
Study ID: NCT02048059
Interventions
Study Description
Brief Summary: This is a Phase 2 study to see if an investigational drug, ANG1005, can shrink tumor cells in breast cancer patients with recurrent brain metastases.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Arizona Cancer Center, Tucson, Arizona, United States
UC San Diego Moores Cancer Center, La Jolla, California, United States
University of California - LAC Medical Center, Los Angeles, California, United States
University of Southern California - Norris Comprehensive Cancer Center, Los Angeles, California, United States
UC - Irvine Chao Family Comprehensive Cancer Center, Orange, California, United States
University of Colorado Cancer Center, Aurora, Colorado, United States
GRU Cancer Center - Georgia Regents University, Augusta, Georgia, United States
Northwestern University, Chicago, Illinois, United States
University of Maryland - Greenebaum Cancer Center, Baltimore, Maryland, United States
National Cancer Institute, Bethesda, Maryland, United States
Cancer & Hematology Centers of Western Michigan, Grand Rapids, Michigan, United States
University of New Mexico, Albuquerque, New Mexico, United States
The Long Islan Brain Tumor Center at Neurological Surgery P.C., Commack, New York, United States
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Cleveland Clinic, Cleveland, Ohio, United States
Magee Womens Hospital, Pittsburgh, Pennsylvania, United States
UPMC Cancer Center, Pittsburgh, Pennsylvania, United States
MD Anderson Cancer Center, Houston, Texas, United States
Univeristy of Texas Health Science Center in San Antonio, San Antonio, Texas, United States
Contact Details
Name: Betty Lawrence
Affiliation: Angiochem Inc
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
